Institute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, St. Petersburg 199004, Russia.
Institute of Experimental Medicine, Acad. Pavlov St. 12, Saint Petersburg 197376, Russia.
Int J Biol Macromol. 2024 Apr;263(Pt 1):130177. doi: 10.1016/j.ijbiomac.2024.130177. Epub 2024 Feb 13.
Polyelectrolyte complexes (PECs) based on polysaccharides, including hyaluronic acid (HA) and chitosan (CS), are promising delivery systems for antimicrobial agents, including oral administration of the peptide antibiotic colistin (CT). Modification of CS with different targeting ligands to improve intestinal permeability is a suitable way to improve the oral bioavailability of polyelectrolyte particles. This study describes the procedure for obtaining CT-containing PECs based on HA and CS modified with cyanocobalamin (vitamin B12). In this case, vitamin B12 is used as a targeting ligand because it is absorbed in the ileum via specific transporter proteins. The resulting PECs had a hydrodynamic size of about 284 nm and a positive ζ-potential of about 26 mV; the encapsulation efficiency was 88.2 % and the CT content was 42.2 μg/mg. The developed systems provided a two-phase drug release: about 50 % of the CT was released in 0.5-1 h, and about 60 % of the antibiotic was cumulatively released in 5 h. The antimicrobial activity of encapsulated CT was maintained at the same level as the pure drug for at least 24 h (minimum inhibitory concentration against Pseudomonas aeruginosa was 2 μg/mL for both). In addition, the apparent permeability coefficient of CT in the PEC formulation was 2.4 × 10 cm/s. Thus, the incorporation of CT into HA- and vitamin B12-modified CS-based PECs can be considered as a simple and convenient method to improve the oral delivery of CT.
基于多糖的聚电解质复合物(PECs),包括透明质酸(HA)和壳聚糖(CS),是抗菌剂的有前途的递送系统,包括多肽抗生素黏菌素(CT)的口服给药。用不同的靶向配体修饰 CS 以提高肠道通透性是提高聚电解质颗粒口服生物利用度的合适方法。本研究描述了基于 HA 和 CS 的 CT 载药 PECs 的制备方法,其中 CS 用氰钴胺素(维生素 B12)修饰。在这种情况下,维生素 B12 被用作靶向配体,因为它通过特定的转运蛋白在回肠中被吸收。所得 PECs 的水动力粒径约为 284nm,ζ-电位约为 26mV;包封效率为 88.2%,CT 含量为 42.2μg/mg。所开发的系统提供了两相药物释放:约 50%的 CT 在 0.5-1h 内释放,约 60%的抗生素在 5h 内累积释放。包封 CT 的抗菌活性在至少 24h 内保持与纯药物相同的水平(对铜绿假单胞菌的最小抑菌浓度,两者均为 2μg/mL)。此外,CT 在 PEC 制剂中的表观渗透系数为 2.4×10cm/s。因此,将 CT 掺入基于 HA 和维生素 B12 修饰的 CS 的 PEC 中可以被认为是提高 CT 口服递送的简单方便的方法。